Skip to main content
Fig. 1 | World Journal of Surgical Oncology

Fig. 1

From: Expression of UGP2 and CFL1 expression levels in benign and malignant pancreatic lesions and their clinicopathological significance

Fig. 1

EnVision immunohistochemical staining (× 200) to evaluate positive (a) and negative (b) UGP2 expression in moderately differentiated adenocarcinoma, positive CFL1 expression in highly differentiated adenocarcinoma (c), negative CFL1 expression in moderately differentiated adenocarcinoma (d), positive UGP2 expression in paracancerous tissue (e), positive UGP2 expression in adenoma (f), positive CFL1 expression in grade II intraepithelial neoplasia (g), and positive CFL1 expression in chronic pancreatitis (h)

Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us